Remedy Science Lands Series A Led by L Catterton

Remedy Science, a skincare brand built on dermatologist expertise and consumer education, has closed a Series A funding round. L Catterton led the investment. Norwest, an existing backer, participated alongside new investor Sonoma Brands Capital.

The company translates clinical dermatology into accessible products. It positions itself as education-first, prioritizing ingredient transparency and skin health literacy over marketing hype. That approach has resonated with consumers seeking medical credibility in their skincare routines.

L Catterton is the largest global consumer-focused private equity firm. Its portfolio includes beauty and wellness brands. Norwest is a venture and growth equity firm with a history in consumer investments. Sonoma Brands Capital focuses on early-stage consumer companies.

The clinical skincare segment has attracted increased venture funding in recent years. Several dermatologist-founded brands have raised capital, reflecting investor interest in medical-grade consumer products. Remedy Science's education-first model differentiates it from competitors that rely more on clinical credentials alone.

The size of the round was not disclosed. Remedy Science did not specify how it will use the proceeds. The company is based in Los Angeles.